Felix Schumacher

Felix Schumacher

Company: Roche

Job title: Program Leader Targeted Therapeutics

Seminars:

Live Q&A with Your Expert Speakers 3:30 pm

Read more

day: Day One

Kick-off Panel Discussion: Exploring the Biggest Hurdles of Crossing the Blood-Brain Barrier (BBB) & Considerations for Overcoming Them 8:40 am

Why are efforts in brain delivery not yet equivalent to CNS drug discovery? Exploring the current state-of-the-art approaches to targeting the BBB delivery of therapeutics including receptor-mediated transcytosis, nanotechnology strategies, intranasal drug delivery and BBB disruption technologies Is receptor-mediated transcytosis the most effective option for intravenous drug delivery to the brain?  What approaches can we…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.